How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Veterinary Rapid Test Market
- By Test Type: Immunochromatographic Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Lateral Flow Assays, Agglutination Tests, Fluorescent Immunoassays
- By Animal Type: Companion Animals, Livestock, Poultry, Aquatic Animals, Equine
- By Disease Type: Infectious Diseases, Parasitic Diseases, Metabolic Disorders, Reproductive Disorders, Nutritional Deficiencies
- By End User: Veterinary Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Farmers and Livestock Owners, Veterinary Pharmacies
- By Sample Type: Blood, Serum, Feces, Urine, Saliva
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Immunochromatographic Tests leads By Test Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 310 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Veterinary Rapid Test Market report
A complete, evidence-based study - 12 chapters and 130 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Test Type 5
Animal Type 5
Disease Type 5
End User 5
Sample Type 5
Companies profiled
Zoetis Inc.
IDEXX Laboratories Inc.
Abaxis
Inc. (a Zoetis company)
Biogal-Galed Labs Ltd.
Thermo Fisher Scientific Inc.
Mast Group Ltd.
Bionote Inc.
VETSCAN (Zoetis brand)
Heska Corporation
Agrolabo S.p.A.
BioNote Inc.
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Zoetis Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →IDEXX Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Abaxis
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Inc. (a Zoetis company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Biogal-Galed Labs Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mast Group Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Bionote Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →VETSCAN (Zoetis brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Heska Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Agrolabo S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioNote Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Neogen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Randox Laboratories Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Merck Animal Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Bio-Rad Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,214M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Immunochromatographic Tests50.6
- Enzyme-Linked Immunosorbent Assay (ELISA)11.5
- Lateral Flow Assays14.6
- Agglutination Tests12.2
- Fluorescent Immunoassays11.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$304.6M → $653.1M · 10.0%
Europe$212.3M → $537.1M · 12.3%
Asia Pacific$193.9M → $447.3M · 11.0%
Latin America$120.0M → $318.9M · 13.0%
Middle East and Africa$92.3M → $207.0M · 10.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.502026
11.512027
11.542028
11.532029
11.552030
11.562031
11.582032
11.592033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Zoetis Inc.9.6
- IDEXX Laboratories Inc.23.7
- Abaxis11.7
- Inc. (a Zoetis company)11.1
- Biogal-Galed Labs Ltd.9.6
- Thermo Fisher Scientific Inc.6.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Test Type11.1%
Animal Type25.9%
Disease Type28.0%
End User15.9%
Sample Type19.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.2
- Europe24.8
- Asia Pacific20.7
- Latin America14.7
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. | 80 | 88 | 86 | 93 | 97 | 82 | 88 |
| IDEXX Laboratories Inc. | 79 | 84 | 82 | 91 | 86 | 93 | 86 |
| Abaxis | 68 | 71 | 79 | 83 | 78 | 78 | 76 |
| Inc. (a Zoetis company) | 66 | 60 | 67 | 71 | 78 | 70 | 69 |
| Biogal-Galed Labs Ltd. | 70 | 71 | 53 | 64 | 67 | 71 | 66 |
| Thermo Fisher Scientific Inc. | 58 | 67 | 69 | 56 | 56 | 65 | 62 |
| Mast Group Ltd. | 50 | 59 | 55 | 58 | 56 | 43 | 54 |
| Bionote Inc. | 58 | 41 | 46 | 50 | 54 | 35 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Zoetis Inc.
- IDEXX Laboratories Inc.
- Abaxis
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Zoetis Inc. | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| IDEXX Laboratories Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Abaxis | ✓ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Inc. (a Zoetis company) | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Biogal-Galed Labs Ltd. | ✓ | ◐ | − | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific Inc. | ◐ | ◐ | ✓ | ◐ | − | − |
| Mast Group Ltd. | ◐ | − | ◐ | − | − | − |
| Bionote Inc. | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Zoetis Inc.88
2IDEXX Laboratories Inc.86
3Abaxis76
4Inc. (a Zoetis company)69
5Biogal-Galed Labs Ltd.66
6Thermo Fisher Scientific Inc.62
7Mast Group Ltd.54
8Bionote Inc.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Zoetis Inc.IDEXX Laboratories Inc.
Challenger2
Strong scale, closing on the leaders.
AbaxisInc. (a Zoetis company)
Contender2
Focused players with pockets of strength.
Biogal-Galed Labs Ltd.Thermo Fisher Scientific Inc.
Niche2
Specialists in a single segment or region.
Mast Group Ltd.Bionote Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Test Type in North America, then scale across Veterinary Rapid Test Market — a $101M beachhead inside a $1.58B market.
Beachhead (SOM)$101Mobtainable near-term
Serviceable (SAM)$660Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Immunochromatographic Tests
Best fit — highest urgency & budget in Test Type.
Economic buyer80 fit
Enzyme-Linked Immunosorbent Assay (ELISA)
Strong fit — clear ROI and a fast path to value.
End user70 fit
Lateral Flow Assays
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Test Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Animal Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Disease Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Test Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Veterinary Rapid Test Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified24%
Evaluation13%
Closed-won6%
$16.0KCAC
$74KLTV
4.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Veterinary Rapid Test Market is a durable-growth opportunity — $4.04B by 2033, compounding at 8.6%.
TAM · 2025$2.09Btoday
TAM · 2033$4.04Bforecast
CAGR8.6%2027–2033
Cumulative$26.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.04BTotal addressable market
SAM$1.64BServiceable available market
SOM$311MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Test Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Test Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.04BLarge & growingTAM by 2033 at 8.6% CAGR
$1.64BServiceable nowreachable with today’s model
$311MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.15BBear5.6% CAGR
$4.04BBase8.6% CAGR
$5.17BBull11.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Animal Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Veterinary Rapid Test Market — a $7.41B market by 2033. Plan: grow share from 7.5% to 12.2%.
Market size · 2033$7.41Btotal addressable
Market CAGR6.8%2027–2033
Target share12.2%from 7.5% today
Revenue ambition$904Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.5% | 12.2% | Behind |
| Revenue | $551M | $904M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.7% | 45.5% | Behind |
| Customer retention | 84.9% | 93.3% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Test Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Animal Type capability
A defensible second engine — invest in Animal Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Test Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Animal Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $119M capacity & capability investment
- Greenlight bolt-on M&A in Animal Type
- Authorise North America expansion plan
- Fund R&D program for Test Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Veterinary Rapid Test Market conversation — a $2.20B market you can size, segment and defend in minutes.
Market size · 2033$2.20Btotal opportunity
Growth8.7%CAGR to 2033
Addressable buyers1,293+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Test Type
Goal Grow share in Test Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 2 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Zoetis Inc.IDEXX Laboratories Inc.AbaxisInc. (a Zoetis company)Biogal-Galed Labs Ltd.Thermo Fisher Scientific Inc.Mast Group Ltd.Bionote Inc.+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Veterinary Rapid Test Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Veterinary Rapid Test Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Veterinary Rapid Test Kit Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportVeterinary Rapid Testing Kit Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVeterinary Rapid Diagnostic Test Kit Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportVeterinary Rapid Diagnostic Assays Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVeterinary Radiology Software Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportVeterinary Radiological System Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVeterinary Radiography X-ray Generators Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVeterinary Radiography Flat Panel Detectors Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportVeterinary Radiography Acquisition System Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVeterinary Rabies Vaccine Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportVeterinary Pump Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportVeterinary Protective Boot Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.